Policy: In the start of what appears to be a regular bi-annual series of
roundtables, the Health Minister saw the main representatives of both the medicines industry and health consumer groups in Melbourne yesterday.
Reimbursement: Vertex has taken the extraordinary step of revealing
the PBAC sought a 90 per cent discount before rejecting its latest cystic fibrosis
drug for a third time, and is calling on Health Minister Greg Hunt to intervene.
PBAC in major denial mode
The PBAC either rejected or deferred 16 major submissions and resubmissions at its July meeting with another three parallel submissions held off because TGA data was insufficient; only seven majors were recommended for listing.